Folks may be interested in these sections from this medical research review:
Accellerated cancer drug outcomes, Incentives for Clinical Trials, Covid Infection risk groups for death, hospitalization from 7 million vaccinated patient reviews:
medpagetoday.com/podcasts/h...
From the tracking of Cancer Drugs that were accellerated, remember that melanoma immunotherapies fell into this category. Looking at intermediate outcomes like tumor shrinkage should be compared with final outcome points like total survival time and NED.
Be well,
Missy
Seeking Melanoma Specialist West Coast
